4 free views remaining today

fibrodysplasia ossificans progressiva

ICD-10 Codes

Related ICD-10:

Description

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder that affects the development and growth of bones, muscles, and other soft tissues in the body.

Characteristics:

  • FOP is characterized by the gradual replacement of muscle tissue and connective tissue (such as tendons and ligaments) with bone [1][2].
  • This process can occur spontaneously or as a result of trauma or injury to the affected area [3].
  • The condition is often accompanied by congenital malformations, such as abnormalities in the shape or structure of bones and joints [4].

Symptoms:

  • Pain and stiffness in the affected areas
  • Limited mobility and range of motion
  • Swelling and redness at the site of new bone growth
  • Gradual loss of muscle mass and function

Causes and Risk Factors:

  • FOP is caused by a mutation in the ACVR1 gene, which codes for a protein involved in the regulation of bone growth [5].
  • The condition is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the disorder [6].

Treatment and Management:

  • There is currently no cure for FOP, but various treatments can help manage symptoms and slow disease progression.
  • Medications such as corticosteroids and bisphosphonates may be used to reduce inflammation and prevent further bone growth.
  • Physical therapy and rehabilitation can also help maintain mobility and function.

References:

[1] Jul 15, 2022 — Fibrodysplasia ossificans progressiva is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone [1].

[2] Fibrodysplasia ossificans progressiva (FOP) is an extremely rare genetic connective tissue disorder characterized by the abnormal development of bone in areas [2].

[3] Nov 29, 2022 — Fibrodysplasia ossificans progressiva is a rare genetic condition where new bone growth replaces muscles and connective tissue [3].

[4] by EM Shore · 2012 · Cited by 48 — Fibrodysplasia ossificans progressiva (FOP): A human genetic disorder of extra-skeletal bone formation, or - How does one tissue become another? Eileen M Shore [4].

[5] Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder that causes muscles, tendons, and other soft tissues to turn permanently into bone [5].

[6] an extremely rare connective tissue disease in which fibrous connective tissue such as muscle, tendons, and ligaments turn into bone tissue [6].

Additional Characteristics

  • FOP is characterized by the gradual replacement of muscle tissue and connective tissue (such as tendons and ligaments) with bone.
  • Pain and stiffness in the affected areas
  • Swelling and redness at the site of new bone growth
  • Gradual loss of muscle mass and function

Signs and Symptoms

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by the gradual replacement of muscles, tendons, and other soft tissues with bone. This process, known as heterotopic ossification, can lead to severe deformities, loss of mobility, and significant disability.

Early Signs:

  • Malformed big toes that are present at birth (congenital) [3][4]
  • Shortened and turned-in big toes, which may be described as "baby bunions" or the toes being curved inward [4][8]
  • Missing a joint in the big toe, making it stiff [5]

Symptoms:

  • Episodes of muscle swelling and inflammation followed by rapid ossification after trauma to a muscle [1]
  • Difficulty speaking and eating as the mouth becomes affected [1]
  • Pain and swelling in joints
  • Stiffness in the joints
  • Low-grade fever
  • Abnormal vertebral morphology (abnormal vertebrae)
  • Abnormality of the first metatarsal bone
  • Alopecia (hair loss)
  • Anemia
  • Aplasia/hypoplasia of the skin [7]

Other Complications:

  • Shoulder pain, aches, soreness, or discomfort [10]
  • Difficulty moving or walking due to joint stiffness and deformities

It's essential to note that FOP is a rare condition, and these symptoms may not be present in every individual with the disorder. If you suspect someone has FOP, it's crucial to consult with a medical professional for an accurate diagnosis and proper care.

References: [1] - Context result 1 [3] - Context result 3 [4] - Context result 4 [5] - Context result 5 [7] - Context result 7 [8] - Context result 8 [10] - Context result 10

Additional Symptoms

  • Shoulder pain, aches, soreness, or discomfort
  • Malformed big toes that are present at birth (congenital)
  • Shortened and turned-in big toes, which may be described as 'baby bunions' or the toes being curved inward
  • Missing a joint in the big toe, making it stiff
  • Episodes of muscle swelling and inflammation followed by rapid ossification after trauma to a muscle
  • Difficulty speaking and eating as the mouth becomes affected
  • Pain and swelling in joints
  • Stiffness in the joints
  • Abnormal vertebral morphology (abnormal vertebrae)
  • Abnormality of the first metatarsal bone
  • hypoplasia of the skin
  • Difficulty moving or walking due to joint stiffness and deformities
  • anemia
  • low-grade fever
  • hair loss

Diagnostic Tests

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by the abnormal development of bone. Diagnostic testing for FOP involves a combination of clinical evaluation, imaging studies, and genetic testing.

Clinical Evaluation The diagnosis of FOP is made by clinical evaluation, which includes a physical examination and medical history [5]. A healthcare provider will look for signs of heterotopic ossification, such as abnormal bone growth in the skin or muscles. They may also perform a skeletal survey to identify any abnormalities in the bones.

Imaging Studies Imaging studies can help confirm the diagnosis of FOP. Plain radiographs (X-rays) can show subtle great toe abnormalities and the presence of heterotopic ossification [5]. Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scans may also be used to evaluate the extent of bone growth.

Genetic Testing Genetic testing is available to confirm a diagnosis of FOP. This involves analyzing DNA samples for mutations in the ACVR1 gene, which is associated with the condition [6]. Genetic testing can determine whether an individual has FOP or not.

Other Diagnostic Tests In addition to clinical evaluation and genetic testing, other diagnostic tests may be used to rule out other conditions that may have similar symptoms. These include:

  • Blood tests: To evaluate for any underlying medical conditions that may be contributing to the symptoms.
  • Skeletal survey: A series of X-rays taken to evaluate the bones and identify any abnormalities.

It's worth noting that a definitive diagnosis of FOP can only be made through clinical evaluation, imaging studies, and genetic testing. A healthcare provider will use these diagnostic tests in combination with a thorough medical history and physical examination to confirm the diagnosis.

References: [5] - The diagnosis of FOP is made by clinical evaluation. Plain radiographs can substantiate more subtle great toe abnormalities and the presence of heterotopic ossification. [6] - Genetic testing can determine whether you have fibrodysplasia ossificans progressiva.

Additional Diagnostic Tests

  • Blood tests
  • Genetic testing
  • Skeletal survey
  • Plain radiographs (X-rays)
  • Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scans

Treatment

Current Treatment Options for Fibrodysplasia Ossificans Progressiva (FOP)

Fibrodysplasia ossificans progressiva, also known as FOP, is a rare and debilitating genetic disorder that leads to the gradual replacement of muscle and other soft tissues with bone. While there is no established medical treatment for FOP, recent advancements have led to the approval of several medications aimed at managing its symptoms.

Approved Medications

  • Palovarotene (Sohonos): In 2023, the US Food and Drug Administration (FDA) approved palovarotene as the first treatment for fibrodysplasia ossificans progressiva. Palovarotene is a retinoic acid receptor agonist that has been shown to slow down the progression of new bone growth in patients with FOP [7][9].
  • Garetosmab: Although not specifically approved for FOP, garetosmab has been studied as a potential treatment option. In one clinical trial, it was found to decrease total lesion activity by nearly 25% compared to placebo [8].

Other Investigational Therapies

Several medications are currently undergoing clinical trials for the treatment of fibrodysplasia ossificans progressiva, including:

  • Rapamycin: This medication has been investigated as a potential treatment option for FOP, although its efficacy is still being studied [3].
  • Palovarotene and rapamycin: These two medications are currently being tested in combination to assess their potential benefits in treating FOP [4].

Supportive Care

While these treatments aim to manage the symptoms of FOP, supportive care remains essential for patients with this condition. This includes high-dose glucocorticoids, which have a limited use in managing inflammation and pain associated with FOP [2].

It is essential to note that each patient's experience with FOP can vary significantly, and treatment plans should be tailored to individual needs.

References:

[1] Sohonos approved for fibrodysplasia ossificans progressiva (2023) [2] Medical management of fibrodysplasia ossificans progressiva [3] Investigational therapies for fibrodysplasia ossificans progressiva [4] Palovarotene and rapamycin in combination for FOP treatment [7] Sohonos (palovarotene) approved as first FDA-approved treatment for people with fibrodysplasia ossificans progressiva [8] Garetosmab decreases total lesion activity by nearly 25% compared to placebo [9] US FDA approves Ipsen's Sohonos™ (palovarotene) capsules, the first and only treatment for people with fibrodysplasia ossificans progressiva

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder that can be challenging to diagnose due to its rarity and similarity in symptoms with other conditions. The differential diagnosis for FOP includes several conditions that may present with similar clinical features.

Conditions to Consider:

  • Progressive osseous heteroplasia: This condition is characterized by the abnormal development of bone tissue, which can lead to skeletal malformations and progressive ossification.
  • Osteosarcoma: A type of bone cancer that can cause pain, swelling, and deformity in affected bones.
  • Lymphedema: A condition characterized by swelling in one or more extremities due to lymphatic obstruction or dysfunction.
  • Soft tissue sarcoma: A rare type of cancer that affects the soft tissues of the body, such as muscles, tendons, and fat cells.
  • Desmoid tumors: A type of benign tumor that can grow rapidly and cause pain and deformity in affected areas.

Key Features to Distinguish FOP from Other Conditions:

  • Hallux valgus: A congenital malformation of the big toe, which is a hallmark feature of FOP.
  • Heterotopic ossification: The abnormal development of bone tissue outside of the skeleton, which can lead to progressive ossification and skeletal deformity.

Diagnostic Considerations:

  • Genetic testing: Genetic analysis can confirm the presence of mutations in the ACVR1/ALK2 gene, which is associated with FOP.
  • Imaging studies: Radiographic imaging can help identify heterotopic ossification and other skeletal malformations characteristic of FOP.

References:

  • [5] Fibrodysplasia ossificans progressiva is commonly misdiagnosed as aggressive juvenile fibromatosis, lymphedema, or soft tissue sarcoma.
  • [6] There are no formal diagnostic criteria for FOP. An FOP diagnosis is suspected in a proband with hallux malformation and heterotopic ossification.
  • [3] Differential diagnosis includes progressive osseous heteroplasia, osteosarcoma, lymphedema, soft tissue sarcoma, desmoid tumors (see these terms), aggressive fibromatosis, scleroderma, CREST syndrome, juvenile fibromatosis, and dermatomyositis.
  • [9] FOP is caused by mutations in the ACVR1/ALK2 gene on chromosome 2q24, which encodes activin A receptor type I/activin-like kinase 2, a bone morphogenetic protein (BMP) receptor.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8467
owl#annotatedSource
t403286
oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:13374
core#notation
DOID:13374
oboInOwl#hasDbXref
UMLS_CUI:C0016037
IAO_0000115
A connective tissue disease that is characterized by progressive ossification of skeletal muscle, fascia, tendons, and ligaments and has_material_basis_in heterozygous mutation in the ACVR1 gene.
rdf-schema#label
fibrodysplasia ossificans progressiva
oboInOwl#hasExactSynonym
Stone Man Syndrome
rdf-schema#subClassOf
t403625
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/M61.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.